Author:
Marshall Danielle,Roboz Gail J.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology
Reference61 articles.
1. Issa JP. The myelodysplastic syndrome as a prototypical epigenetic disease. Blood. 2013;121(19):3811–7. doi: 10.1182/blood-2013-02-451757 .
2. Pang WW, Pluvinage JV, Price EA, Sridhar K, Arber DA, Greenberg PL, et al. Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes. Proc Natl Acad Sci U S A. 2013;110(8):3011–6. doi: 10.1073/pnas.1222861110 .
3. Greenberg PL. The multifaceted nature of myelodysplastic syndromes: clinical, molecular, and biological prognostic features. J Natl Compr Canc Netw. 2013;11(7):877–85.
4. Howlader NNA, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, et al., editors. SEER cancer statistics review, 1975–2010: section 30 Myelodysplastic Syndromes (MDS), Chronic Myeloproliferative Disorders (CMD), and Chronic Myelomonocytic Leukemia (CMML). Bethesda: National Cancer Institute; 2013. http://seer.cancer.gov/csr/1975_2010/ . Accessed August 15, 2013 2013.
5. Sekeres MA. Epidemiology, natural history, and practice patterns of patients with myelodysplastic syndromes in 2010. J Natl Compr Canc Netw. 2011;9(1):57–63.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献